First randomized trial finds AI-supported mammography screening is safe and almost halves radiologist workload

An interim safety analysis of the first randomized controlled trial of its kind involving over 80,000 Swedish women published in The Lancet Oncology journal, finds artificial intelligence (AI)-supported mammography analysis is as good as two breast radiologists working together to detect breast cancer, without increasing false positives and almost halving the screen-reading workload.